MYOG and cancer: On the other hand, with cancer cachexia, TNF-α-mediated inhibition of myogenin and MyoD, and activation of p53-dependent cell death proteins, leads to the inhibition of myogenic differentiation via upregulation of atrogin-1 to enhance apoptosis and atrophy [68,77,78].